Such a great way to start 2022! Congratulations @MariaJubran , the leading author of our newly published paper “Overcoming resistance to EGFR monotherapy in HNSCC by identification and inhibition of individualized cancer processes” and the team ! https://t.co/qrZwfFMpEN